tiprankstipranks
Trending News
More News >
TipRanksTop Financial ExpertsInsidersThird Rock Ventures IV, L.P.

Third Rock Ventures IV, L.P. Insider Profile

4 Followers
Third Rock Ventures IV, L.P., Ten Percent Owner at Dianthus Therapeutics, holds 14.73M shares in Tango Therapeutics (Ticker: TNGX), holds 7.02M shares in Maze Therapeutics, Inc. (Ticker: MAZE), holds 3.06M shares in Dianthus Therapeutics (Ticker: DNTH). Most recently, Third Rock Ventures IV, L.P. Sold ― shares of Tango Therapeutics on Sep 09, 2025 for an estimated value of $5.11M.
tipranks
Third Rock Ventures IV, L.P.

Third Rock Ventures IV, L.P.
Dianthus Therapeutics (DNTH)
Ten Percent Owner

Ranked #4,193 out of 103,431 Corporate Insiders

Profitable Transactions

88%
14 out of 16 Profitable Transactions

Average Return

+24.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$399M
28.76%
27.26%
25.17%
14.57%
4.25% Others
A breakdown of Third Rock Ventures IV, L.P.'s holdings

Insider Roles

Maze Therapeutics, Inc.
(MAZE)
Ten Percent Owner
Dianthus Therapeutics
(DNTH)
Ten Percent Owner
Tango Therapeutics
(TNGX)
Ten Percent Owner
Revolution Medicines
(RVMD)
Ten Percent Owner
+1 other positions
Roles that Third Rock Ventures IV, L.P. holds in companies

Most Profitable Insider Trade

Stock:
Tango Therapeutics
(TNGX)
Rating:Informative Sell
Date:Feb 21, 2024 - Feb 21, 2025
Return:+78.60%
The most profitable trade made by Third Rock Ventures IV, L.P.

Third Rock Ventures IV, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dianthus Therapeutics
Feb 09, 2023
Ten Percent Owner
Informative Sell
3.06M
$108.78M
Fulcrum Therapeutics
Jul 22, 2019
Ten Percent Owner
Uninformative Buy
$16.96M
Revolution Medicines
Feb 18, 2020
Ten Percent Owner
Uninformative Buy
$58.13M
Tango Therapeutics
Sep 09, 2025
Ten Percent Owner
Informative Sell
5.11M
$100.44M
Maze Therapeutics, Inc.
Feb 04, 2025
Ten Percent Owner
Uninformative Buy
$114.78M
List of latest transactions for each holding click on a transaction to see Third Rock Ventures IV, L.P.'s performance on stock

Third Rock Ventures IV, L.P. insider profile FAQ

What is the percentage of profitable transactions made by Third Rock Ventures IV, L.P.?
The percentage of profitable transactions made by Third Rock Ventures IV, L.P. is 88%.
    What is the average return per transaction made by Third Rock Ventures IV, L.P.?
    The average return per transaction made by Third Rock Ventures IV, L.P. is 24.10%.
      What stocks does Third Rock Ventures IV, L.P. hold?
      Third Rock Ventures IV, L.P. holds: DNTH, FULC, RVMD, TNGX, MAZE stocks.
        What was Third Rock Ventures IV, L.P.’s latest transaction?
        Third Rock Ventures IV, L.P. latest transaction was an Informative Sell of $5.11M.
          What was Third Rock Ventures IV, L.P.'s most profitable transaction?
          Third Rock Ventures IV, L.P.’s most profitable transaction was an Informative Sell of TNGX stock on February 21, 2024. The return on the trade was 78.60%.
            What is Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics?
            Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.